Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Vitoria

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysisNathan Ford, Zara Shubber, Joseph N Jarvis, et al.
AIDS (London, England)|December 11, 2014
Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysisNathan Ford, Cadi Irvine, Zara Shubber, et al.
AIDS (London, England)|May 23, 2014
Optimal strategies for monitoring response to antiretroviral therapy in HIV-infected adults, adolescents, children and pregnant women: a systematic reviewJoseph D Tucker, Cedric H Bien, Philippa J Easterbrook, et al.
AIDS (London, England)|May 11, 2018
The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?Marco Vitoria, Andrew Hill, Nathan Ford, et al.
American Journal of Clinical Pathology|May 23, 2009
The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectivesMarco Vitoria, Reuben Granich, Charles F Gilks, et al.
Current Opinion in HIV and AIDS|June 15, 2010
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and updateReuben Granich, Siobhan Crowley, Marco Vitoria, et al.
Open Forum Infectious Diseases|November 28, 2022
A Systematic Review of COVID-19 Vaccine Antibody Responses in People With HIVHelen M Chun, Kyle Milligan, Elfriede Agyemang, et al.
Antiviral Therapy|August 18, 2012
Determinants of HIV drug resistance and public health implications in low- and middle-income countriesSilvia Bertagnolio, Andrea De Luca, Marco Vitoria, et al.
AIDS (London, England)|January 25, 2013
Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysisZara Shubber, Alexandra Calmy, Isabelle Andrieux-Meyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic reviewNathan Ford, Zara Shubber, Alexandra Calmy, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysisNathan Ford, Zara Shubber, Joseph N Jarvis, et al.
AIDS (London, England)|December 11, 2014
Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysisNathan Ford, Cadi Irvine, Zara Shubber, et al.
AIDS (London, England)|May 23, 2014
Optimal strategies for monitoring response to antiretroviral therapy in HIV-infected adults, adolescents, children and pregnant women: a systematic reviewJoseph D Tucker, Cedric H Bien, Philippa J Easterbrook, et al.
AIDS (London, England)|May 11, 2018
The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?Marco Vitoria, Andrew Hill, Nathan Ford, et al.
American Journal of Clinical Pathology|May 23, 2009
The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectivesMarco Vitoria, Reuben Granich, Charles F Gilks, et al.
Current Opinion in HIV and AIDS|June 15, 2010
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and updateReuben Granich, Siobhan Crowley, Marco Vitoria, et al.
Open Forum Infectious Diseases|November 28, 2022
A Systematic Review of COVID-19 Vaccine Antibody Responses in People With HIVHelen M Chun, Kyle Milligan, Elfriede Agyemang, et al.
Antiviral Therapy|August 18, 2012
Determinants of HIV drug resistance and public health implications in low- and middle-income countriesSilvia Bertagnolio, Andrea De Luca, Marco Vitoria, et al.
AIDS (London, England)|January 25, 2013
Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysisZara Shubber, Alexandra Calmy, Isabelle Andrieux-Meyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic reviewNathan Ford, Zara Shubber, Alexandra Calmy, et al.
Pageof 10